​CE for Pharmacists & Technicians: Dynamic Diabetes Updates: Current Management Guidelines for Type 2 Diabetes

by Denise L. Walbrandt Pigarelli, PharmD, BC-ADM, Francesca Johnson, PharmD, BCACP, MEd, Elizabeth A. Buckley, PharmD, CDCES, Joseph R. Dutzy, PharmD

Learning Objectives:

• Evaluate the key updates to the 2024 ADA Standards of Care in Diabetes and the impact on therapeutic decision-making
• Assess modifications and updates in the 2023 AACE Algorithm for diabetes management and the impact of these changes on patient care, medication selection, and monitoring practices
• Discuss the similarities and differences among guidelines, especially related to how pharmacists can integrate them collaboratively to promote a comprehensive, patient-centered approach to diabetes management
• Examine the nuances of diabetes management in people with diabetes over age 65 based on the Endocrine Society guidelines for the treatment of diabetes in older adults, with considerations for their specific needs
• Explain the nuances of treating diabetes in youth and during pregnancy

​

Keywords: Type 2 Diabetes Mellitus, Semaglutide, Exenatide, Dipeptidyl-Peptidase IV Inhibitors, Liraglutide, Cardiovascular Diseases, Glycated Hemoglobin, Glycoside Hydrolase Inhibitors, Goals, Pioglitazone, Dulaglutide, Tirzepatide, Albuminuria, Glomerular Filtration Rate, Secondary Prevention, Social Determinants of Health, Risk Factors, Obesity, Body Weight, Weight Loss, Glucose, Heart Failure, Chronic Renal Insufficiency, Risk Reduction Behavior, Heart Disease Risk Factors, Healthy Lifestyle, Patient-Centered Care, Dyslipidemia, Hypertension, Metformin, Insulins, Language, Smoking, Sodium​

Download PDF

2024 May/June Table of Contents